Miles P. Hacker - Concepedia

Author

Miles P. Hacker

Also Known As

John D. Roberts, M Hacker, M P Hacker, M. P. HACKER, M. P. Hacker, M.P. Hacker, MILES P. HACKER, Miles Hacker, Miles P Hacker, Miles P. Hacker

145

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of Vermont Regional Cancer Center Anderson Hospital

About

Miles P. Hacker is an author at University of Vermont specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	36	1.6K
2	Natural Sciences	12	16	600
3	Allergy	3	3	105
4	Engineering	2	2	38
5	Public Health	1	1	24

Miles P. Hacker

Publications

Citations

H-Index

Page 1

	Year	Citations
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs Susan L. Kelley, Alakananda Basu, Beverly A. Teicher, Science	1988	604
Antineoplastic cyclic peptides from the marine tunicate Lissoclinum patella Chris M. Ireland, Augustine R. Durso, Robert A. Newman, The Journal of Organic Chemistry Bioorganic ChemistryPeptide EngineeringAltmetric Attention ScoreMolecular BiologyOrganic Chemistry	1982	177
Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes Nicholas P. Farrell, Yun Qu, Miles P. Hacker Journal of Medicinal Chemistry	1990	161
Partial Purification of Human Lymphocyte-Activating Factor (LAF) by Ultrafiltration and Electrophoretic Techniques Lawrence B. Lachman, Miles P. Hacker, Robert E. Handschumacher The Journal of Immunology Laf ActivityImmunologyProtein PurificationBioanalysisAnalytical Chemistry	1977	124
Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Lori Hazlehurst, Nils E. Foley, Mary Gleason-Guzman, PubMed Hematological MalignancyMolecular PharmacologyVitro Drug ResistanceMultiple MechanismsMedicine	1999	115
Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines Lawrence B. Lachman, Miles P. Hacker, Gershwin T. Blyden, Cellular Immunology InflammationLymphocyte-activating FactorGranulocyteImmunologyLymphatic System	1977	114
6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor Evaluations A. Paul Krapcho, M. E. PETRY, Zelleka Getahun, Journal of Medicinal Chemistry	1994	103
Chemical properties and antitumor activity of complexes of platinum containing substituted sulfoxides [PtCl(R'R''SO)(diamine)]NO3. Chirality and leaving-group ability of sulfoxide affecting biological activity Nicholas P. Farrell, Donna M. Kiley, Wendy Schmidt, Inorganic Chemistry Chemical AnalysisAltmetric Attention ScoreChemistryChemical BiologyPharmaceutical Chemistry	1990	101
B16 Murine Melanoma and Aging: Slower Growth and Longer Survival in Old Mice23 William B. Ershler, James A. Stewart, Miles P. Hacker, JNCI Journal of the National Cancer Institute ImmunologyImmunoeditingPathologyCell ProliferationImmunotherapy	1984	101
Mechanisms of Asbestos-induced Nitric Oxide Production by Rat Alveolar Macrophages in Inhalation and in vitro Models 11Supported by grants from NHLBI (RO1 HL39469) and NIEHS (RO1 03878). T R Quinlan, Kelly BéruBé, Miles P. Hacker, Free Radical Biology and Medicine InflammationLung InflammationMedicineReactive Nitrogen SpeciePhysiology	1998	82

Page 1